Hepatitis B in Transition in Mauritania: HBsAg seroprevalence in patients attending the Cheikh Zayed National Hospital, Nouakchott (2019–2020) | Synapse
March 3, 2026
Hepatitis B in Transition in Mauritania: HBsAg seroprevalence in patients attending the Cheikh Zayed National Hospital, Nouakchott (2019–2020)
Key Points
HBsAg seroprevalence reveals significant infection rates among patients attending the hospital.
The study observed an HBsAg seroprevalence of X%, highlighting the ongoing challenge of Hepatitis B in the region.
Observational analysis conducted at Cheikh Zayed National Hospital over the years 2019 to 2020.
These findings underline the need for targeted public health strategies and potential vaccination campaigns.